Although overall CV mortality has declined in recent years, patients with clinically manifest CVD remain at increased risk of recurrent CV events. A group of HCPs at UK primary and secondary care centres have recently developed a consensus statement to improve delivery of secondary prevention in the UK.
It has been suggested high blood pressure may be associated with increased risk of death in hospitalised Coronavirus infected subjects. On non-medical social media sites and some newspapers it has been suggested that commonly used drugs ACEi and ARBs may increase both the risk of infection and the severity of SARS-CoV2 (the virus causing this infection), which has led to some patients stopping their medication.
This article provides a pragmatic approach for primary care following NICE’s update to their guidance on identification and management of familial hypercholesterolaemia (CG 71) published in November 2017.